Clinical Trial Update: Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study

View source ↗

Summary

Clinical trial update for the ARISE study evaluating vaginal microbiome as a biomarker for vaginal health in women with breast cancer; the sponsor is Ohio State…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Breast Neoplasms | Status: COMPLETED